These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

19 related articles for article (PubMed ID: 17311761)

  • 1.
    Drescher R; Greiser J; Gröber S; Weisheit T; Freesmeyer M
    J Nucl Med; 2024 May; 65(5):822. PubMed ID: 38485269
    [No Abstract]   [Full Text] [Related]  

  • 2. Arginine-glycine-aspartate (RGD)-targeted positron-labeled dendritic polylysine nanoprobe for tumor PET imaging.
    Fang Q; Xiao Y; Zhang R; Yin J; Xie D; Wang X
    RSC Adv; 2020 Jun; 10(39):23276-23285. PubMed ID: 35520297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-prostate cancer activity of 8-hydroxyquinoline-2-carboxaldehyde-thiosemicarbazide copper complexes in vivo by bioluminescence imaging.
    Xie F; Cai H; Peng F
    J Biol Inorg Chem; 2018 Aug; 23(6):949-956. PubMed ID: 30006867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular imaging and therapy targeting copper metabolism in hepatocellular carcinoma.
    Wachsmann J; Peng F
    World J Gastroenterol; 2016 Jan; 22(1):221-31. PubMed ID: 26755872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brachytherapy using injectable seeds that are self-assembled from genetically encoded polypeptides in situ.
    Liu W; McDaniel J; Li X; Asai D; Quiroz FG; Schaal J; Park JS; Zalutsky M; Chilkoti A
    Cancer Res; 2012 Nov; 72(22):5956-65. PubMed ID: 23155121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems.
    Garrison JC; Rold TL; Sieckman GL; Figueroa SD; Volkert WA; Jurisson SS; Hoffman TJ
    J Nucl Med; 2007 Aug; 48(8):1327-37. PubMed ID: 17631556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin alpha v beta 3.
    Cai W; Wu Y; Chen K; Cao Q; Tice DA; Chen X
    Cancer Res; 2006 Oct; 66(19):9673-81. PubMed ID: 17018625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular imaging of gastrin-releasing peptide receptor-positive tumors in mice using 64Cu- and 86Y-DOTA-(Pro1,Tyr4)-bombesin(1-14).
    Biddlecombe GB; Rogers BE; de Visser M; Parry JJ; de Jong M; Erion JL; Lewis JS
    Bioconjug Chem; 2007; 18(3):724-30. PubMed ID: 17378600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.
    Chen X; Park R; Hou Y; Tohme M; Shahinian AH; Bading JR; Conti PS
    J Nucl Med; 2004 Aug; 45(8):1390-7. PubMed ID: 15299066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and characterization of theranostic poly(HPMA)-c(RGDyK)-DOTA-64Cu copolymer targeting tumor angiogenesis: tumor localization visualized by positron emission tomography.
    Yuan J; Zhang H; Kaur H; Oupicky D; Peng F
    Mol Imaging; 2013 May; 12(3):203-12. PubMed ID: 23490439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of Poly[APMA]-DOTA-64Cu conjugates for interventional radionuclide therapy of prostate cancer: assessment of intratumoral retention by micro-positron emission tomography.
    Yuan J; You Y; Lu X; Muzik O; Oupicky D; Peng F
    Mol Imaging; 2007; 6(1):10-7. PubMed ID: 17311761
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.